A 3D Renal Proximal Tubule on Chip Model Phenocopies Lowe Syndrome and Dent II Disease Tubulopathy.
Sindhu NaikAndrew R WoodMaté OngenaertPaniz SaidiyanEdo D ElstakHenriëtte L LanzJan StallenRichard JanssenElizabeth SmytheKai S ErdmannPublished in: International journal of molecular sciences (2021)
Lowe syndrome and Dent II disease are X-linked monogenetic diseases characterised by a renal reabsorption defect in the proximal tubules and caused by mutations in the OCRL gene, which codes for an inositol-5-phosphatase. The life expectancy of patients suffering from Lowe syndrome is largely reduced because of the development of chronic kidney disease and related complications. There is a need for physiological human in vitro models for Lowe syndrome/Dent II disease to study the underpinning disease mechanisms and to identify and characterise potential drugs and drug targets. Here, we describe a proximal tubule organ on chip model combining a 3D tubule architecture with fluid flow shear stress that phenocopies hallmarks of Lowe syndrome/Dent II disease. We demonstrate the high suitability of our in vitro model for drug target validation. Furthermore, using this model, we demonstrate that proximal tubule cells lacking OCRL expression upregulate markers typical for epithelial-mesenchymal transition (EMT), including the transcription factor SNAI2/Slug, and show increased collagen expression and deposition, which potentially contributes to interstitial fibrosis and disease progression as observed in Lowe syndrome and Dent II disease.
Keyphrases
- epithelial mesenchymal transition
- chronic kidney disease
- end stage renal disease
- transcription factor
- case report
- poor prognosis
- dna methylation
- peritoneal dialysis
- emergency department
- newly diagnosed
- signaling pathway
- ejection fraction
- gene expression
- circulating tumor cells
- cell cycle arrest
- single cell
- drug induced
- patient reported